VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MCK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MCKMcKesson Corporation
$1082.59$126.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. MCK
  4. Financial Ratios

McKesson Corporation (MCK) Financial Ratios

Latest Ratios: P/E Ratio 26.9x · EV/EBITDA 17.3x · ROE N/A. (1997–2026 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

MCK Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Market Cap$126.3B$107.4B$86.2B$72.0B$50.6B$47.2B$31.3B$24.6B$23.1B$29.4B$33.1B
Enterprise Value$131.0B$112.0B$87.9B$74.8B$53.2B$51.2B$34.5B$30.0B$27.7B$34.6B$38.8B
P/E Ratio →26.8822.5526.1723.9814.2242.34—27.33688.59440.226.52
P/S Ratio0.300.270.240.230.180.180.130.110.110.140.17
P/B Ratio——————21.663.672.392.562.62
P/FCF18.2919.8516.5019.8511.0012.108.036.366.647.827.91
P/OCF20.5317.4514.1716.699.8110.646.905.635.726.786.97

P/E links to full P/E history page with 30-year chart

MCK EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
EV / Revenue—0.280.240.240.190.190.140.130.130.170.20
EV / EBITDA17.3115.6017.5516.4010.5214.707.837.636.888.959.10
EV / EBIT20.2917.3719.0518.5510.9224.30—21.5431.7066.385.39
EV / FCF—20.7116.8220.6211.5713.138.837.767.969.209.28

MCK Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Gross Margin3.6%3.6%3.5%3.9%4.3%4.8%4.9%4.9%5.0%5.0%5.4%
Operating Margin1.6%1.6%1.2%1.3%1.6%1.0%1.5%1.3%1.4%1.4%1.7%
Net Profit Margin1.2%1.2%0.9%1.0%1.3%0.4%-1.9%0.4%0.0%0.0%2.6%

Return on Capital

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
ROE——————-111.3%11.0%0.3%0.6%45.0%
ROA6.0%6.0%4.6%4.6%5.7%1.7%-7.2%1.5%0.1%0.1%8.8%
ROIC254.1%254.1%540.6%252.3%199.7%60.1%31.6%17.1%14.9%12.5%15.3%
ROCE44.8%44.8%30.5%26.7%30.5%15.2%17.8%14.8%13.5%11.9%14.3%

MCK Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Debt / Equity——————6.501.400.780.680.68
Debt / EBITDA1.201.201.481.621.442.172.142.391.892.042.00
Net Debt / Equity——————2.160.800.480.450.46
Net Debt / EBITDA0.650.650.340.620.521.150.711.371.151.351.35
Debt / FCF—0.860.330.770.571.030.801.391.331.381.38
Interest Coverage26.1126.1118.0316.5919.6711.83-22.205.593.311.8423.37

MCK Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Current Ratio0.850.850.900.920.920.951.030.991.021.011.04
Quick Ratio0.490.490.530.510.510.570.590.600.580.570.61
Cash Ratio0.060.060.090.090.100.070.140.090.080.070.08
Asset Turnover—4.904.784.584.444.173.663.773.593.453.26
Inventory Turnover16.0616.0615.0714.0413.4513.4411.7813.1312.1812.1412.30
Days Sales Outstanding—25.3226.0725.5425.6025.7029.3931.5231.0731.0333.49

MCK Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Dividend Yield0.3%0.4%0.4%0.4%0.6%0.6%0.9%1.2%1.3%0.9%0.8%
Payout Ratio8.0%8.0%10.5%10.5%8.2%24.9%—32.7%858.8%391.0%4.9%

Total Shareholder Return Metrics

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Earnings Yield3.7%4.4%3.8%4.2%7.0%2.4%—3.7%0.1%0.2%15.3%
FCF Yield5.5%5.0%6.1%5.0%9.1%8.3%12.5%15.7%15.1%12.8%12.6%
Buyback Yield3.8%4.4%3.6%4.2%7.2%7.5%2.4%7.9%7.1%5.8%7.0%
Total Shareholder Yield4.0%4.8%4.0%4.6%7.8%8.0%3.3%9.1%8.4%6.7%7.8%
Shares Outstanding—$124M$128M$134M$142M$154M$161M$182M$197M$209M$223M

Key Metrics

Growth RegimeExpanding
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Thin margin and working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q2)

Premium Multiple Prices in Specialty Growth

At a 27.64 trailing P/E and 17.88 EV/EBITDA, McKesson trades well above Henry Schein's 12.47 EV/EBITDA, and as reported in the supplied peer data the premium appears to reflect expectations of specialty and oncology-driven earnings expansion rather than current margin strength.

The forward P/E of 23.76 compresses the trailing multiple by roughly 14%, which suggests the market expects recent EPS strength to persist into the next twelve months. Relative to Cardinal Health's 37.58 P/E, McKesson screens cheaper, though Cardinal's elevated multiple appears distorted by its near-zero reported net margin of 0.7%. Investors should treat the multiple as a bet on earnings durability given that net margins have oscillated between 0.3% and 1.7% across the last ten quarters.

Razor-Thin Spread Limits Earning Power

Gross margin of 3.6% and operating margin of 1.6% in 2027Q2 leave McKesson with minimal buffer, and the 1.1% net margin shows how sensitive reported earnings remain to non-operating and one-time items.

Operating margin has ranged from 0.8% to 2.3% across the ten quarters, indicating that the distribution spread is stable in direction but narrow in magnitude. The gap between operating and net margin in several quarters may suggest below-the-line items such as legal accruals or interest expense are material relative to core earnings. Operating margin, rather than net margin, appears to be the cleaner read of underlying earning power for this business.

Interest Coverage Tightens Amid Rising Debt

Interest coverage of 6.20x in 2027Q2 sits below the 8.45x of 2027Q1 and well below the 33.84x peak in 2026Q4, and based on reported figures, debt-to-EBITDA has been volatile between 3.52x and 8.45x across the period.

The coverage swings appear driven more by quarterly EBITDA fluctuation than by a steady debt-service trend, which makes the current 6.20x reading an incomplete signal on its own. Negative shareholders' equity renders debt-to-equity uninformative, so EBITDA-based leverage measures are the relevant gauge. Investors should monitor whether coverage holds above roughly 5x through the next two quarters, as a sustained decline would warrant closer scrutiny of refinancing exposure.

Sub-One Current Ratio Relies on Turnover

A current ratio of 0.90 and quick ratio of 0.52 in 2027Q2 indicate current liabilities exceed current assets, and according to recent SEC filings, cash of $6.5B provides only partial coverage of short-term obligations.

A current ratio consistently below 1.0 is characteristic of distributors that fund inventory with supplier credit, so the level alone does not necessarily signal distress. The quick ratio's dependence on inventory conversion, with DIO near 23 days, means liquidity is tied to rapid turnover. Under a severe stress scenario involving supplier term contraction, the thin buffer would be tested quickly, and this dependence warrants monitoring.

Negative Cash Conversion Cycle Funds Operations

A cash conversion cycle of negative 8 days in 2027Q2 and 2027Q1, combined with DPO of 57 days against DIO of 23 days, suggests McKesson relies on supplier financing, and as reported in the quarterly data, asset turnover of 1.23x supports the volume-driven model.

The negative CCC has widened from roughly -3 days in 2025Q3 to -8 days recently, meaning the company appears to be extracting progressively more working capital from suppliers relative to its inventory cycle. This structure may explain much of the cash flow volatility observed elsewhere, since working capital swings can reverse quickly if payment terms normalize. The durability of this advantage depends on continued supplier acceptance of extended terms.

Supplier Financing Could Reverse Quickly

The bull case rests on McKesson's negative cash conversion cycle and recent EPS beat, yet based on reported figures the working capital benefit is the most reversible component of the earnings and cash profile.

If the widening negative CCC reflects temporary favorable payment timing rather than durable terms, a normalization toward neutral working capital would remove a meaningful share of recent operating cash flow. Combined with a 1.6% operating margin, even modest pricing pressure or a 340B-related volume reduction could shift the trajectory quickly. Investors should weigh whether the current forward P/E of 23.76 already discounts a sustained working capital tailwind that may not persist.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open MCK Terminal

MCK Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MCK — Frequently Asked Questions

Quick answers to the most common questions about buying MCK stock.

What is McKesson Corporation's P/E ratio?

McKesson Corporation's current P/E ratio is 26.9x. The historical average is 21.7x. This places it at the 75th percentile of its historical range.

What is McKesson Corporation's EV/EBITDA?

McKesson Corporation's current EV/EBITDA is 17.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.4x.

Is MCK stock overvalued?

Based on historical data, McKesson Corporation is trading at a P/E of 26.9x. This is at the 75th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is McKesson Corporation's dividend yield?

McKesson Corporation's current dividend yield is 0.28% with a payout ratio of 8.0%.

What are McKesson Corporation's profit margins?

McKesson Corporation has 3.6% gross margin and 1.6% operating margin.

How much debt does McKesson Corporation have?

McKesson Corporation's Debt/EBITDA ratio is 1.2x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.